-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HNDauVZo1YdyP0pXMLfWd9bS5gN+foDFOscgjCWo2CAMF7+2ZyMNByTmOVJ0BY8d hdWzg4Hp/3GTRSTmfImghQ== 0001005477-05-003164.txt : 20050908 0001005477-05-003164.hdr.sgml : 20050908 20050908154338 ACCESSION NUMBER: 0001005477-05-003164 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20050103 FILED AS OF DATE: 20050908 DATE AS OF CHANGE: 20050908 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000727510 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222372868 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 685 ROUTE 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 7329804500 MAIL ADDRESS: STREET 1: C/O DORSEY & WHITNEY LLP STREET 2: 250 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10177 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICAL INC DATE OF NAME CHANGE: 20021210 FORMER COMPANY: FORMER CONFORMED NAME: ENZON INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEBUHN ROBERT CENTRAL INDEX KEY: 0001007931 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12957 FILM NUMBER: 051075303 MAIL ADDRESS: STREET 1: 222 S 15TH STREET STREET 2: SUITE 600 N CITY: OMAHA STATE: NE ZIP: 68102 4 1 edgar123.xml FORM 4 X0202 4 2005-01-03 0 0000727510 ENZON PHARMACEUTICALS INC ENZN 0001007931 LEBUHN ROBERT C/O ENZON PHARMACEUTICALS, INC. 685 ROUTE 202/206 BRIDGEWATER NJ 08807 1 0 0 0 Common Stock (right to buy) 13.77 2005-01-03 4 A 0 15000 0 A 2006-01-03 2015-01-03 Common Stock 15000 15000 D Restricted Stock Unit 0 2005-07-01 4 A 0 3765 0 A Common Stock 3765 3765 D Annual option granted to Independent Directors of Enzon Pharmaceuticals, Inc. ("Enzon") pursuant to Enzon's 2001 Incentive Stock Plan and qualified under Rule 16b-3(d). Annual restricted stock units granted by Enzon pursuant to Enzon's 2001 Incentive Stock Plan and qualified under Rule 16b-3(d). Of the 3,765 units granted, 1,255 will vest on July 1, 2006, 1,255 will vest on July 1, 2007 and the remaining 1,255 will vest on July 1, 2008. /s/ Lawrence R. Miller (Attorney-in-fact) 2005-09-08 EX-24 2 lebuhn.htm lebhun

POWER OF ATTORNEY

         Know all by these presents, that the undersigned hereby constitutes and appoints each of Craig A. Tooman and Lawrence R. Miller, signing singly, the undersigned’s true and lawful attorney-in-fact to:

  (1) execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director of Enzon Pharmaceuticals, Inc. (the “Company”), Forms 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

  (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 4 or 5 and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

  (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

         The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

         This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 4 and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. All previous powers of attorney with respect to the subject matter hereof, including Forms 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, are hereby revoked.

         IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 7th day of September, 2005.

  
/s/ Robert Lebuhn
——————————————————————
Signature


Robert Lebuhn
——————————————————————
Print Name

-----END PRIVACY-ENHANCED MESSAGE-----